Long-term goal: The broad objectives of this renewal are to understand the mechanism(s) by which mitochondrial neurotoxins such as 1-methyl-4-phenylpyridinium (MPP+) selectively destroy dopaminergic neurons in the substantia nigra, leading to the development of Parkinson's disease (PD). Reactive oxygen and nitrogen species (ROS/RNS)-mediated damage has been implicated in age-related neurodegenerative diseases like PD. Hypothesis: (i) MPP+ generates mitochondria superoxide (02*) and hydrogen peroxide (H202), and inactivates mitochondrial iron-sulfur-proteins (e.g., aconitase). This stimulates transferrin receptor (TfR)-mediated uptake of iron. (ii) MPP+-induced H202 and iron transported through TfR cause enhanced degradation of tetrahydrobiopterin (BH4), an essential co-factor for neuronal nitric oxide synthase (nNOS), tyrosine hydroxylase (TH), and dihydropteridine reductase (DHPR) activities. BH, depletion causes """"""""uncoupling"""""""" of nNOS to form O2* and inactivation of TH and DHPR leading to dopamine depletion. (iii) MPP+-induced O2*, H2O2, and Tf-iron stimulate aggregation of a-synuclein, a neuronal presynaptic protein leading to apoptosis or programmed cell death.
Aims : 1.) Investigate the effect of TfR-dependent iron and mitochondrial ROS in neuronal cell apoptosis in response to MPP+. 2.) Assess the modulatory effect of BH4 depletion on nNOS-generated nitric oxide ('NO)/O2* ratio and on BH4-dependent enzyme controlling dopamine synthesis. 3.) Elucidate the role of ROS, Tf-iron and BH4 depletion on a-synuclein aggregation and apoptosis in neuronal cells treated with MPP+. Methods: We will use both dopaminergic and non-dopaminergic cells (neuroblastoma and cerebellar granule neurons). The following redox-parameters will be measured: GSH and lipid peroxides; aconitase, complex-I, and iron-regulatory activities; TfR expression and 55Fe uptake; a-synuclein expression and aggregation; caspase activation and apoptosis. ROS/RNS will be determined by fluorescence and spin-trapping techniques. Significance: PD affects about 1% of population over the age of 50. Emerging data allude to environmental mitochondrial toxins as a causative factor. Novelty: This proposal sheds new light on the synergistic role for MPP*-induced mitochondrial ROS, iron, BH4-induced nNOS uncoupling, dopamine depletion and alpha-synuclein aggregation in neuronal toxicity of PD and other mitochondrial diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS039958-05
Application #
6771259
Study Section
Neurodegeneration and Biology of Glia Study Section (NDBG)
Program Officer
Refolo, Lorenzo
Project Start
2000-04-10
Project End
2008-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
5
Fiscal Year
2004
Total Cost
$330,963
Indirect Cost
Name
Medical College of Wisconsin
Department
Biophysics
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Langley, Monica; Ghosh, Anamitra; Charli, Adhithiya et al. (2017) Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice. Antioxid Redox Signal 27:1048-1066
Ghosh, Anamitra; Langley, Monica R; Harischandra, Dilshan S et al. (2016) Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease. J Neuroimmune Pharmacol 11:259-78
Charli, Adhithiya; Jin, Huajun; Anantharam, Vellareddy et al. (2016) Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model. Neurotoxicology 53:302-313
Gendelman, Howard E; Anantharam, Vellareddy; Bronich, Tatiana et al. (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine 11:751-67
Jin, Huajun; Kanthasamy, Arthi; Ghosh, Anamitra et al. (2014) Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim Biophys Acta 1842:1282-94
Michalski, Radoslaw; Michalowski, Bartosz; Sikora, Adam et al. (2014) On the use of fluorescence lifetime imaging and dihydroethidium to detect superoxide in intact animals and ex vivo tissues: a reassessment. Free Radic Biol Med 67:278-84
Dranka, Brian P; Gifford, Alison; McAllister, Donna et al. (2014) A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease. Neurosci Lett 583:159-64
Dranka, Brian P; Gifford, Alison; Ghosh, Anamitra et al. (2013) Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹??¹G) transgenic mouse. Neurosci Lett 549:57-62
Michalski, Radoslaw; Zielonka, Jacek; Hardy, Micael et al. (2013) Hydropropidine: a novel, cell-impermeant fluorogenic probe for detecting extracellular superoxide. Free Radic Biol Med 54:135-47
Ghosh, Anamitra; Kanthasamy, Arthi; Joseph, Joy et al. (2012) Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. J Neuroinflammation 9:241

Showing the most recent 10 out of 32 publications